Slide 1: First quarter
Medical Solutions Engineered Solutions First quarter CEO Christer Wahlquist CFO Per-Ola Holmström 6 May, 2025
Slide 2: Q1 summary – Nolato Group
Q1 summary – Nolato Group A global solutions provider established on three continents ● Sales amounted to SEK 2,453 million (2,442) - Adjusted for currency, a decrease of 1% SEKm 12000 - Growth for Medical Solutions but lower sales for Engineered Solutions 11000 10000 ● Operating profit (EBITA) rose
Slide 3: One Group – two business areas
One Group – two business areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for selected Development and manufacture of complex Design, development, industrialization and global customers comprises development and product systems and components for medical manufa
Slide 4: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 1,397 171 3000 2500 SALES EBITA 2000 SEKm, Q1 SEKm, Q1 1500 57 12.2 1000 500 SHARE OF THE GROUP EBITA MARGIN %, Q1 %, Q1 0 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 R12M 4 4
Slide 5: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug Delivery In-vitro-diagnostics (IVD) Endoskopy & General Surgery Cardiology Contincence care Pharma Packaging Other 5
Slide 6: Medical Solutions – Q1
Medical Solutions – Q1 ● Sales growth of 3% - Adjusted for currency an increase of 2% - Most market areas experienced stable volumes Q1 Full year - Drug Delivery market area continued to grow SEKm 2025 2024 2024 2023 - Surgery stabilized - IVD showed lower volumes Sales 1,397 1,355 5,434 5,308 ● EBI
Slide 7: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 4000 1,058 107 3500 3000 SALES EBITA 2500 SEKm, Q1 SEKm, Q1 2000 1500 43 10.1 1000 500 SHARE OF THE GROUP EBITA MARGIN 0 %, Q1 %, Q1 05 06 07 08 09 10 11 12 13 14 15 16 17 18 1
Slide 8: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer Electronics Automotive Other Hygiene 8
Slide 9: Engineered Solutions – Q1
Engineered Solutions – Q1 ● Sales decrease of 3% Q1 Full year - Adjusted for currency, a decrease of 3% SEKm 2025 2024 2024 2023 - As expected, volumes to the Automotive industry declined - Other market areas had stable volumes Sales 1,058 1 ,087 4,243 4,245 - Materials business showed sharply incre
Slide 10: Group financial highlights
Group financial highlights Full Q1 Q1 year SEKm 2025 2024 R12M 2024 Net sales 2,453 2,442 9,675 9,664 Operating profit (EBITA) 271 238 991 958 EBITA margin (%) 11.0 9.7 10.2 9.9 Profit after financial income and expense 252 209 891 848 Profit after tax 199 162 695 658 Effective tax (%) 21.0 22.5 22.
Slide 11: Current situation
Current situation Medical Solutions Engineered Solutions • Maintained growth strategy • Advanced market positions • Focus on margin – cost adjustments, pricing strategy • Established position in new product areas and efficiency • Focus on innovative and sustainable solutions • Innovation and sustain
Slide 12: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini